Detalhe da pesquisa
1.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856617
2.
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
Lancet Oncol
; 24(8): e344-e354, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541280
3.
Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study.
Lancet Oncol
; 22(12): 1692-1704, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774225
4.
Multidisciplinary Care for Melanoma of Unknown Primary: Experience in the Era of Molecular Profiling.
Ann Surg Oncol
; 27(13): 5240-5247, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32909128
5.
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Cancer
; 125(1): 18-44, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30281145
6.
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Cancer
; 124(22): 4332-4341, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303516
7.
Nivolumab plus ipilimumab in melanoma brain metastases - Authors' reply.
Lancet Oncol
; 23(2): e54, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114123
8.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334439
9.
Tumor-infiltrating lymphocytes are associated with improved survival in node-positive Merkel cell carcinoma: A national cohort analysis.
J Am Acad Dermatol
; 86(5): 1172-1174, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33932537
10.
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.
Lancet Oncol
; 16(8): 908-18, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26115796
11.
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
Cancer
; 121(3): 432-440, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25250858
12.
Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach.
J Natl Compr Canc Netw
; 13(6): 811-22, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26085395
13.
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.
Proc Natl Acad Sci U S A
; 109(12): 4592-7, 2012 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22393002
14.
Kidney cancer, version 2.2014.
J Natl Compr Canc Netw
; 12(2): 175-82, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24586079
15.
The Dance Between Tumor Molecular Biology and Antitumor Immune Response.
Clin Cancer Res
; 30(2): 257-259, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988415
16.
After a treatment breakthrough-progress, plateaus, and raising the bar.
Cancer
; 123(S11): 2087-2088, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28543696
17.
An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.
Cancer
; 118(17): 4098-104, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22281842
18.
A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial.
Invest New Drugs
; 30(2): 741-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20967484
19.
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564126
20.
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).
J Immunother Cancer
; 10(9)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175037